Tuesday's IBD 50 Stocks To Watch pick is biotech stock Travere Therapeutics, which is pulling back to a key support level. That makes the kidney disease leader one of the best ideas to watch right now ...
Type 2 diabetes can lead to diabetic kidney disease, but a class of drugs that cause the kidneys to remove glucose through urine has been gaining attention.